Trailing-twelve-month (TTM) revenue is $124.61 Million with a year-over-year growth of (2.20%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $32,009,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $30,788,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-11 |
| Q1 FY2026Period ended 2026-03-31 | $30,123,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $31,685,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $124,605,000 |
Current P/S: $271,956,140 market capitalization ÷ $124,605,000 TTM revenue = 2.18x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:31:46.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $31.68M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:47:35.161Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Deposit Account | $7M | $7M |
| Fiduciary and Trust | $8M | $10M |
$124.61M
$124.61 Million
(2.20%)
vs. $127.41M a year ago (TTM)
+9.95%
5 Year compound annual growth rate
1 Year
(2.20%)
3 Year
+13.99%
5 Year
+9.95%
10 Year
+9.02%
15 Year
+7.82%
20 Year
+6.22%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $124.24M | ($1.18M) | (0.94%) |
| 2024 | $125.42M | +$30.41M | +32.01% |
| 2023 | $95.01M | +$14.97M | +18.70% |
| 2022 | $80.04M | +$4.05M | +5.33% |
| 2021 | $75.99M | ($2.50M) | (3.18%) |
| 2020 |
TTM Growth
(2.20%)
3-Year CAGR
+13.99%
5-Year CAGR
+9.95%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $78.49M |
| +$1.53M |
| +1.99% |
| 2019 | $76.96M | +$11.90M | +18.29% |
| 2018 | $65.06M | +$10.71M | +19.72% |
| 2017 | $54.35M | +$467,000 | +0.87% |
| 2016 | $53.88M | +$1.80M | +3.45% |
